Topical Interferon Gamma-1b for Central Serous Chorioretinopathy

NCT01468337 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Retinal Disease
Macular Disease

Interventions

DRUG: Interferon gamma-1b

Sponsor

National Eye Institute (NEI)

Collaborators

[object Object]